| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.4 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.093 | 0.4 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |